日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mechanism of Saikosaponin D in regulating ferroptosis in patient-derived lung adenocarcinoma organoids via upregulation of ATF3/CHOP/CHAC1 signaling.

柴胡皂苷 D 通过上调 ATF3/CHOP/CHAC1 信号通路调节患者来源的肺腺癌类器官中铁死亡的机制。

Li Jia, Ma Qiong, Huang Chunxia, Zeng Xiao, He Jiawei, You Liting, Zhuang Xiang, Xiao Ping, You Fengming, Ren Yifeng, Zheng Chuan

Transcriptomic Determinants of Circulating Immunity Predict Immune-Related Adverse Events (irAEs) in Cancer Patients Receiving PD-1/PD-L1 Blockade

循环免疫的转录组决定因素可预测接受PD-1/PD-L1阻断治疗的癌症患者的免疫相关不良事件(irAEs)

You, Liting; Zhai, Jianzhao; Xin, Zhaodan; Na, Feifei; Wen, Yang; Li, Jin; Song, Jiajia; Bai, Ling; Zhou, Xiaohan; Ying, Binwu; Zhou, Juan

Chitosan activates NLRP3 inflammasome and cGAS-STING to suppress cancer progression through hexokinase 2 dissociation and mitochondrial dysfunction.

壳聚糖激活 NLRP3 炎症小体和 cGAS-STING,通过己糖激酶 2 解离和线粒体功能障碍抑制癌症进展

Li Lu, You Liting, Bi Zhenfei, Zhang Ziqi, Ying Binwu, Luo Min, Wei Xiawei

Circulating immunological transcriptomic profile identifies DDX3Y and USP9Y on the Y chromosome as promising biomarkers for predicting response to programmed death 1/programmed death ligand 1 blockade

循环免疫转录组学分析发现,Y染色体上的DDX3Y和USP9Y是预测程序性死亡受体1/程序性死亡配体1阻断疗法疗效的潜在生物标志物。

You, Liting; Xin, Zhaodan; Na, Feifei; Chen, Min; Wen, Yang; Li, Jin; Song, Jiajia; Bai, Ling; Zhai, Jianzhao; Zhou, Xiaohan; Ying, Binwu; Zhou, Juan

Advancing lung organoids toward clinical applications: a global perspective on research focus and future directions

推进肺类器官的临床应用:全球研究重点和未来方向展望

Wang, Qian; Tan, Shiyan; Fu, Xi; He, Jiawei; Ma, Qiong; You, Fengming; You, Liting; Ren, Yifeng

Enhanced multi-omics analysis reveals a lncRNA signature with 12 RNA modifications to predict tumor heterogeneity and potential therapy in non-small cell lung cancer

增强型多组学分析揭示了一种包含12种RNA修饰的lncRNA特征,可用于预测非小细胞肺癌的肿瘤异质性和潜在治疗方法。

You, Hua; Fan, Mingyu; Yin, Limei; Na, Feifei; You, Liting

Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer

去分化过程中 Γδtcr 受体库的动态变化及其对甲状腺癌免疫治疗的初步启示

Hao, Qing; Li, Ruicen; Li, Hancong; Rui, Shu; You, Liting; Zhang, Lingyun; Zhao, Yue; Li, Peiheng; Li, Yuanmin; Kong, Xinagyu; Chen, Haining; Zou, Xiuhe; Liu, Feng; Wang, Xiaofei; Zhou, Juan; Zhang, Weihan; Huang, Libing; Shu, Yang; Liu, JiaYe; Sun, Ronghao; Li, Chao; Zhu, Jingqiang; Jiang, Yong; Wei, Tao; Qian, Kun; Bai, Bing; Hu, Yiguo; Peng, Yong; Dai, Lunzhi; Caulin, Carlos; Xu, Heng; Li, Zhihui; Park, Jihwan; Luo, Han; Ying, Binwu

A two-step infection model: From SARS-CoV-2 entry and trafficking to egress and spread

两步感染模型:从SARS-CoV-2的入侵和传播到病毒的释放和扩散

You, Liting; Ying, Binwu

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer

利用循环微生物组特征预测非小细胞肺癌患者的肿瘤免疫微环境和预后

Zhou, Xiaohan; You, Liting; Xin, Zhaodan; Su, Huiting; Zhou, Juan; Ma, Ying

Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer

通过循环肿瘤DNA谱分析确定的等位基因频率和比例可预测酪氨酸激酶抑制剂治疗非小细胞肺癌的疗效。

Song, Jiajia; Bai, Ling; Zhai, Jianzhao; Xin, Zhaodan; You, Liting; Zhou, Yi; Zhou, Juan; Ying, Binwu